ResMed PE Ratio 2012-2025 | RMD
Current and historical p/e ratio for ResMed (RMD) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ResMed PE ratio as of January 19, 2026 is 26.02.
| ResMed PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-20 | 253.19 | 25.92 | |
| 2025-09-30 | 273.08 | $9.77 | 27.95 |
| 2025-06-30 | 256.85 | $9.51 | 27.01 |
| 2025-03-31 | 222.37 | $8.91 | 24.96 |
| 2024-12-31 | 226.67 | $8.47 | 26.76 |
| 2024-09-30 | 241.44 | $7.55 | 31.98 |
| 2024-06-30 | 188.87 | $6.93 | 27.25 |
| 2024-03-31 | 194.96 | $6.51 | 29.95 |
| 2023-12-31 | 168.92 | $6.05 | 27.92 |
| 2023-09-30 | 144.75 | $6.16 | 23.50 |
| 2023-06-30 | 213.32 | $6.10 | 34.97 |
| 2023-03-31 | 213.39 | $5.87 | 36.35 |
| 2022-12-31 | 202.41 | $5.51 | 36.74 |
| 2022-09-30 | 211.87 | $5.35 | 39.60 |
| 2022-06-30 | 203.07 | $5.31 | 38.24 |
| 2022-03-31 | 234.42 | $5.31 | 44.15 |
| 2021-12-31 | 251.35 | $3.55 | 70.80 |
| 2021-09-30 | 253.91 | $3.41 | 74.46 |
| 2021-06-30 | 237.15 | $3.24 | 73.19 |
| 2021-03-31 | 186.27 | $3.13 | 59.51 |
| 2020-12-31 | 203.67 | $4.79 | 42.52 |
| 2020-09-30 | 163.97 | $4.66 | 35.19 |
| 2020-06-30 | 183.25 | $4.27 | 42.92 |
| 2020-03-31 | 140.25 | $3.53 | 39.73 |
| 2019-12-31 | 147.24 | $3.14 | 46.89 |
| 2019-09-30 | 128.02 | $2.90 | 44.14 |
| 2019-06-30 | 115.29 | $2.80 | 41.18 |
| 2019-03-31 | 97.91 | $3.08 | 31.79 |
| 2018-12-31 | 106.81 | $3.11 | 34.34 |
| 2018-09-30 | 107.81 | $2.32 | 46.47 |
| 2018-06-30 | 96.49 | $2.19 | 44.06 |
| 2018-03-31 | 91.40 | $2.14 | 42.71 |
| 2017-12-31 | 78.32 | $2.00 | 39.16 |
| 2017-09-30 | 70.87 | $2.47 | 28.69 |
| 2017-06-30 | 71.36 | $2.41 | 29.61 |
| 2017-03-31 | 65.64 | $2.29 | 28.66 |
| 2016-12-31 | 56.32 | $2.30 | 24.49 |
| 2016-09-30 | 58.47 | $2.40 | 24.36 |
| 2016-06-30 | 56.80 | $2.43 | 23.37 |
| 2016-03-31 | 51.67 | $2.45 | 21.09 |
| 2015-12-31 | 47.73 | $2.46 | 19.40 |
| 2015-09-30 | 45.06 | $2.46 | 18.32 |
| 2015-06-30 | 49.58 | $2.47 | 20.07 |
| 2015-03-31 | 62.82 | $2.47 | 25.43 |
| 2014-12-31 | 48.84 | $2.46 | 19.86 |
| 2014-09-30 | 42.70 | $2.42 | 17.64 |
| 2014-06-30 | 43.64 | $2.40 | 18.18 |
| 2014-03-31 | 38.33 | $2.29 | 16.74 |
| 2013-12-31 | 40.16 | $2.24 | 17.93 |
| 2013-09-30 | 44.83 | $2.17 | 20.66 |
| 2013-06-30 | 38.11 | $2.10 | 18.15 |
| 2013-03-31 | 39.02 | $2.13 | 18.32 |
| 2012-12-31 | 34.85 | $1.99 | 17.51 |
| 2012-09-30 | 33.78 | $1.88 | 17.97 |
| 2012-06-30 | 25.93 | $1.72 | 15.07 |
| 2012-03-31 | 25.69 | $1.56 | 16.47 |
| 2011-12-31 | 21.11 | $1.46 | 14.46 |
| 2011-09-30 | 23.93 | $1.41 | 16.97 |
| 2011-06-30 | 25.72 | $1.44 | 17.86 |
| 2011-03-31 | 24.93 | $1.41 | 17.68 |
| 2010-12-31 | 28.79 | $1.39 | 20.78 |
| 2010-09-30 | 27.27 | $1.32 | 20.73 |
| 2010-06-30 | 25.27 | $1.23 | 20.54 |
| 2010-03-31 | 26.45 | $1.19 | 22.32 |
| 2009-12-31 | 21.72 | $1.13 | 19.31 |
| 2009-09-30 | 18.78 | $1.05 | 17.97 |
| 2009-06-30 | 16.92 | $0.95 | 17.81 |
| 2009-03-31 | 14.68 | $0.85 | 17.38 |
| 2008-12-31 | 15.57 | $0.78 | 19.97 |
| 2008-09-30 | 17.87 | $0.73 | 24.48 |
| 2008-06-30 | 14.85 | $0.71 | 21.06 |
| 2008-03-31 | 17.53 | $0.69 | 25.40 |
| 2007-12-31 | 21.83 | $0.40 | 54.57 |
| 2007-09-30 | 17.81 | $0.42 | 42.92 |
| 2007-06-30 | 17.14 | $0.42 | 40.82 |
| 2007-03-31 | 20.93 | $0.40 | 52.99 |
| 2006-12-31 | 20.45 | $0.67 | 30.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.591B | $5.146B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.894B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.54 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.102B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.423B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |